(E)-Ethyl 2-((dimethylamino)methylene)-3-oxobutanoate - CAS 203186-58-7
Catalog: |
BB056015 |
Product Name: |
(E)-Ethyl 2-((dimethylamino)methylene)-3-oxobutanoate |
CAS: |
203186-58-7 |
Synonyms: |
ethyl 2-acetyl-3-(dimethylamino)acrylate; (E)-ethyl 2-((dimethylamino)methylene)-3-oxobutanoate; Ethyl 2-((dimethylamino)methylene)-3-oxobutanoate; Ethyl N,N-dimethylaminomethylene acetoacetate; ethyl 2-dimethylaminomethylene-3-oxobutanoate; ethyl (2E)-2-(dimethylaminomethylidene)-3-oxobutanoate; Ethyl 2-[(dimethylamino)methylidene]-3-oxobutanoate |
IUPAC Name: | ethyl (2E)-2-(dimethylaminomethylidene)-3-oxobutanoate |
Description: | (E)-Ethyl 2-((dimethylamino)methylene)-3-oxobutanoate, can be used in the synthesis of N-substituted-[1,2,4]triazoles and 1,2,4-triazolo[3,4-b][1,3,4]thiadiazines having antibacterial activity. |
Molecular Weight: | 185.22 |
Molecular Formula: | C9H15NO3 |
Canonical SMILES: | CCOC(=O)C(=CN(C)C)C(=O)C |
InChI: | InChI=1S/C9H15NO3/c1-5-13-9(12)8(7(2)11)6-10(3)4/h6H,5H2,1-4H3/b8-6+ |
InChI Key: | LQSOVGAUOHMPLK-SOFGYWHQSA-N |
GHS Hazard Statement: | H302+H312+H332 (50%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021152165-A1 | Macrocyclic rip2-kinase inhibitors | 20200131 |
CN-113135937-A | Fused tetracyclic compounds and application thereof in medicines | 20200119 |
WO-2021007477-A1 | Indazoles and azaindazoles as lrrk2 inhibitors | 20190711 |
CA-3145305-A1 | Indazoles and azaindazoles as lrrk2 inhibitors | 20190711 |
CN-111285850-A | Isoindoline compounds, preparation method thereof, pharmaceutical composition and application thereof | 20181206 |
AU-2019392231-A1 | Isoindoline compound, and preparation method, pharmaceutical composition, and application of isoindoline compound | 20181206 |
CA-3122317-A1 | Isoindoline compound, and preparation method, pharmaceutical composition, and application of isoindoline compound | 20181206 |
EP-3896062-A1 | Isoindoline compound, and preparation method, pharmaceutical composition, and application of isoindoline compound | 20181206 |
US-2022041578-A1 | Isoindoline compound, and preparation method, pharmaceutical composition, and application of isoindoline compound | 20181206 |
CA-3111046-A1 | Fused tetracyclic compounds and uses thereof in medicine | 20180930 |
Complexity: | 231 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 1 |
Exact Mass: | 185.10519334 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 185.10519334 |
Rotatable Bond Count: | 5 |
Topological Polar Surface Area: | 46.6Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS